Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Amarna Therapeutics announces appointment of Aurelia Caparrós as new Chief Business Officer | ||
By: GlobeNewswire - 19 Apr 2024 | Back to overview list |
|
Leiden, The Netherlands, 19 April 2024 – Amarna Therapeutics, a privately-held biotechnology company developing transformative gene therapies in a range of rare and prevalent diseases, including Type 1 Diabetes Mellitus, today announces the appointment of Aurelia Caparrós as the Company’s new Chief Business Officer (CBO), effective 1st of April 2024. Aurelia brings more than 25 years of healthcare industry experience with expertise in business development, strategy and global marketing including P&L responsibilities spanning diverse geographies. She held global leadership roles for amongst others Novartis, led multiple enterprise transformation programs and implemented strategic growth initiatives to achieve business goals while fostering the culture of inclusion and enterprise mindset. As the new CBO, she will be responsible for driving Amarna's future growth and expansion, both in the Netherlands and Spain. Her key responsibilities will include identifying assets, companies, and areas of interest, designing tailored partnering structures, and securing attractive deals through the entire deal-making process. Aurelia will also play a crucial role in promoting Amarna as the partner of choice at business partnering meetings and scientific conferences, as well as supporting the company's investor relations and fundraising activities. "We are thrilled to welcome Aurelia Caparrós as our new Chief Business Officer," said Henk Streefkerk, CEO and Medical Director of Amarna Therapeutics BV. "Her exceptional leadership and deep industry expertise will be invaluable as we continue to expand our business and bring our transformative gene therapies to patients in need." === E N D S === About Amarna About Type 1 Diabetes Mellitus More information on www.amarnatherapeutics.com Follow us on LinkedIn For further inquiries please contact: Amarna Therapeutics LifeSpring Life Sciences Communication, Amsterdam Aurelia Caparrós, New Chief Business Officer Amarna Therapeutics, Leiden, The Netherlands Attachment |
||
|
||
Copyright 2024 GlobeNewswire | Back to overview list |